Mater Sociomed
doi: 10.3390/antiox8050111
some work in inflammatory bowel disease (PMID: 22300085) A clinical trial has been registered, though its current status is unclear (PMID: 40756949) Regulatory note: BPC-157 is prohibited by WADA/USADA for sport use (added to the Prohibited List in 2022)
Many successful protocols involve using a stabilized form of glutathione or a delivery system, like liposomes, that protects it until it reaches the target cells
Intra-abdominal hypertension and the abdominal compartment syndrome
Haridoss M, Sasidharan A, Kumar S, Rajsekar K, Venkataraman K, Bagepally BS (2024) Cost-utility analysis of TNF- inhibitors, B cell inhibitors, and JAK inhibitors versus csDMARDs for rheumatoid arthritis treatment